NCT07406022 Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.
| NCT ID | NCT07406022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Régional Metz-Thionville |
| Condition | Skin Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 140 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 140 participants in total. It began in 2025-12-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.
Eligibility Criteria
Inclusion Criteria: * patients with skin carcinomas and actinic keratoses Exclusion Criteria: * minor patient
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07406022 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07406022 currently recruiting?
Yes, NCT07406022 is actively recruiting participants. Contact the research team at projet-recherche-clinique@chr-metz-thionville.fr for enrollment information.
Where is the NCT07406022 trial being conducted?
This trial is being conducted at Metz, France.
Who is sponsoring the NCT07406022 clinical trial?
NCT07406022 is sponsored by Centre Hospitalier Régional Metz-Thionville. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.